• Full P&L and cash flow responsibility of the 2 business units (431 mm $ net sales) for actuals and forecasting processes• Right hand to the Italy and Cluster CFO: steering the team without a CFO in country for 10 months, incl. HC transformation period• Managing a team of 3

• Responsible for ~£64m of cross divisional budget, Finance Business Partner to the UKI SLT (overall team size ~20 people) and to Divisional Finance Controlling Teams • In charge of Corporate Month-End processes and of monthly reporting to the Country CFO• Project Leader to the roll out of the new month end closing tool Blackline (Oct.2021)• Managing a team of 1

• Responsible of the Opex budget for 2 divisions, Consumer Products (L’Oréal Paris, Garnier, Maybelline) and Dermatological Beauty (Vichy, La Roche Posay, CeraVe), bringing synergies and efficiencies via activities’ standardization• Centralization of Business partnering to the Consumer Market Insights (CMI) marketing expenses for all 4 divisions• Driving cost reductions' initiatives such as -10% on travel costs with the help of Power BI and -38% on free products (i.e goodie bags) vs PY

• Change management process: Leading the knowledge transfer of the 4 Global Functions in Iberia, Italy & Middle East from the local finance teams to the newly CoE organization in the UK• Finance business partner to the HR function across EMEA~ 25 HR business partners (~30 mm $) • Coaching 1 junior member of the team

• Finance business partner for Discovery, Early Development & HIV compounds for the Infectious Diseases Therapeutic Area (~100 mm $): supporting the project management teams (~6 people per team with scientific backgrounds) of the covered compound• 10-14 yrs forecast of drug’s development costs, including profitability analysis via NPV calculations of the main compounds• Leading the Dengue compound NPV calculation making sure to present different sensitivity scenarios which allowed the compound to still be funded by Janssen for the following 5 yrs

• Finance business partner to the Preservation & Material Protection Sales team: supporting ~7 sales rep with weekly reports and ad hoc requests• Consolidation & Reporting of EMEA LifeScan Diabetes franchise sales in the local reporting system BPC

• Slovenske Elektrarne, Finance Dep. (Slovakia): Investments’ analysis & profitability through NPV models of Q3-Q4 investments on nuclear and thermal power plants (around 40 investments/15 mm EUR each)• International Division (Italy): Financial analysis on Enel main subsidiary Slovenske Elektrarne

Internship, Operations Department - Foreign Markets, Securities (Bonds & Equities) analysis and settlement, Cash availability analysis for the next day activities.